An Open-Label Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070
Phase of Trial: Phase I
Latest Information Update: 23 Nov 2017
At a glance
- Drugs [18F]-JNJ-64511070 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 23 Nov 2017 Last checked against ClinicalTrials.gov record.
- 26 Sep 2017 Status changed from not yet recruiting to recruiting.
- 08 Sep 2017 New trial record